Page last updated: 2024-12-07

dehydroabietic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dehydroabietic acid is a naturally occurring diterpenoid resin acid found in various coniferous trees, particularly in the resin of pines. It is a white, crystalline solid with a molecular formula of C20H28O2. Dehydroabietic acid has garnered significant interest in research due to its diverse biological activities and potential applications in various fields.

**Synthesis:**

* Dehydroabietic acid can be synthesized through various chemical processes, including:
* Extraction from natural sources like pine resin.
* Chemical modification of other resin acids, such as abietic acid.
* Biocatalytic methods using microbial enzymes.

**Biological Effects:**

* **Antioxidant Activity:** Dehydroabietic acid exhibits potent antioxidant properties, scavenging free radicals and protecting cells from oxidative damage.
* **Anti-inflammatory Activity:** It has demonstrated anti-inflammatory effects, inhibiting the production of inflammatory mediators.
* **Antimicrobial Activity:** Dehydroabietic acid shows promising antimicrobial activity against a range of bacteria and fungi.
* **Anti-cancer Activity:** Studies have indicated potential anticancer properties, inhibiting the growth and proliferation of certain cancer cell lines.

**Importance and Research Focus:**

* **Biofuel Production:** Dehydroabietic acid and other resin acids hold promise as potential renewable feedstocks for biofuel production.
* **Pharmaceutical Applications:** Its diverse biological activities make it a potential candidate for developing new pharmaceuticals, particularly in the fields of anti-inflammatories, antimicrobials, and anticancer agents.
* **Industrial Applications:** Dehydroabietic acid finds applications in various industrial settings, including:
* Additives for resins and polymers.
* Surfactants and emulsifiers.
* Synthesis of other valuable chemicals.

Dehydroabietic acid continues to be a subject of ongoing research, focusing on understanding its mechanisms of action, optimizing its synthesis, and exploring its potential applications in various fields.'

dehydroabietic acid: major aquatic toxicant in effluent of pulp and paper mills [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dehydroabietic acid : An abietane diterpenoid that is abieta-8,11,13-triene substituted at position 18 by a carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

dehydroabietate : A monocarboxylic acid anion that is the conjugate base of dehydroabietic acid, obtained by deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID94391
CHEMBL ID12850
CHEBI ID29571
SCHEMBL ID222078
MeSH IDM0062050

Synonyms (57)

Synonym
4-09-00-02389 (beilstein handbook reference)
unii-0s5xp6s3au
0s5xp6s3au ,
abieta-8,13-trien-18-oic acid
nsc-2952
abietic acid, dehydro-
1,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic acid
podocarpa-8,13-trien-15-oic acid, 13-isopropyl-
13-isopropylpodocarpa-8,13-trien-15-oic acid
1-phenanthrenecarboxylic acid,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1r-(1.alpha.,4a.beta.,10a.alpha.)]-
nsc2952 ,
abieta-8(14),9(11),12-trien-18-oic acid
S3226 ,
einecs 217-102-8
isopropyl podocarpa-8,11,13-trien-15-oic acid
(1r-(1alpha,4abeta,10aalpha))-1,2,3,4,4a,9,10,10a-octahydro-7-isopropyl-1,4a-dimethylphenanthren-1-carboxylic acid
brn 2059290
nsc 2952
1-phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1r-(1alpha,4abeta,10aalpha))-
podocarpa-8,11,13-trien-15-oic acid, 13-isopropyl-
1-phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1r,4as,10ar)-
inchi=1/c20h28o2/c1-13(2)14-6-8-16-15(12-14)7-9-17-19(16,3)10-5-11-20(17,4)18(21)22/h6,8,12-13,17h,5,7,9-11h2,1-4h3,(h,21,22)/t17-,19-,20-/m1/s
abieta-8,11,13-trien-18-oic acid
1740-19-8
13-isopropylpodocarpa-8,11,13-trien-15-oic acid
dehydroabietate
dehydroabietic acid
(-)-dehydroabietic acid
LMPR0104050005
bdbm50143600
1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenecarboxylic acid
CHEBI:29571 ,
CHEMBL12850
AKOS015917291
FT-0633812
SCHEMBL222078
(1r-(1alpha,4abeta,10aalpha))-1,2,3,4,4a,9,10,10a-octahydro- 7-isopropyl-1,4a-dimethylphenanthren-1-carboxylic acid
1-phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a- octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1r,4as,10ar)-
NFWKVWVWBFBAOV-MISYRCLQSA-N
W-107855
mfcd09839012
DTXSID8022163
dehydroabietic acid, >=95% (lc/ms-elsd)
HY-N6869
Q27110153
6980-63-8
rel-(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid
AMY22483
CS-W012130
A881721
5-podocarpa-8,11,13-trien-15-oic acid, 13-isopropyl-
1-phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1r-(1,4a,10a)]-
AC-34629
(1r,4as,10ar)-1,4a-dimethyl-7-(propan-2-yl)-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid
EN300-6730478
(+)-dehydroabietic acid, tech grade
rel-(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylicacid

Research Excerpts

Overview

Dehydroabietic acid (DAA) is a naturally occurring diterpene resin acid derived from coniferous plants such as pinus species. It is a food-derived terpenoid with various bioactivities. It's a major component of rosin.

ExcerptReferenceRelevance
"Dehydroabietic acid is a tricyclic diterpenoid resin acid isolated from rosin. "( Recent Advances on Biological Activities and Structural Modifications of Dehydroabietic Acid.
Du, J; Hao, M; Lv, M; Wen, H; Xu, H; Xu, J; Zhang, S, 2022
)
2.4
"Dehydroabietic acid (DHAA) is a major component of rosin."( Development of indirect competitive ELISA for determination of dehydroabietic acid in duck skin and comparison with the HPLC method.
Geng, Z; Li, P; Ma, J; Qiu, X; Sun, C; Wang, D; Xu, W, 2020
)
1.52
"Dehydroabietic acid (DAA) is a natural phytochemical found in red pine trees and herbal plants. "( Dehydroabietic Acid Induces Regeneration of Collagen Fibers in Ultraviolet B-Irradiated Human Dermal Fibroblasts and Skin Equivalents.
Bae, IH; Hwang, JS; Kang, YG; Kim, DY; Kim, SH; Kim, YJ; Lee, ES; Lee, SH; Lee, TR; Park, NH, 2019
)
3.4
"Dehydroabietic acid (DAA) is a naturally occurring diterpene resin acid derived from coniferous plants such as "( Dehydroabietic Acid Suppresses Inflammatory Response Via Suppression of Src-, Syk-, and TAK1-Mediated Pathways.
Cho, JY; Jo, M; Kang, YG; Kim, D; Kim, E; Kim, JH; Kim, YJ; Lee, TR; Yoo, BC, 2019
)
3.4
"Dehydroabietic acid (DHA) is a naturally occurring diterpene with different and relevant biological activities. "( Synthesis and antiproliferative activity of some novel triazole derivatives from dehydroabietic acid.
Pertino, MW; Schmeda-Hirschmann, G; Theoduloz, C; Verdugo, V, 2014
)
2.07
"Dehydroabietic acid (DHAA) is a specific organic tracer for the pyrolysis of conifer resin. "( Laboratory study on OH-initiated degradation kinetics of dehydroabietic acid.
He, H; Lai, C; Liu, Y; Ma, J; Ma, Q, 2015
)
2.1
"Dehydroabietic acid (DAA) is a naturally occurring diterpene resin acid of confers, such as pinus species (P. "( The natural phytochemical dehydroabietic acid is an anti-aging reagent that mediates the direct activation of SIRT1.
Cho, YU; Choi, DH; Kang, YG; Kim, J; Kim, WG; Lee, JH; Lee, JY; Lee, TR; Miyamoto, Y; No, KT; Park, JS; Seo, DB; Shin, JM, 2015
)
2.16
"Dehydroabietic acid (DHAA) is a resin acid present in aquatic environments shown to induce cellular and molecular damage in aquatic animals. "( Dehydroabietic acid cytotoxicity in goldfish radial glial cells in vitro.
Da Fonte, DF; Gutierrez-Villagomez, JM; Trudeau, VL; Venables, MJ; Xing, L, 2016
)
3.32
"Dehydroabietic acid (DAA) is a food-derived terpenoid with various bioactivities. "( Dehydroabietic acid activates peroxisome proliferator-activated receptor-γ and stimulates insulin-dependent glucose uptake into 3T3-L1 adipocytes.
Ando, C; Ezaki, Y; Goto, T; Hirai, S; Kang, MS; Kawada, T; Nishimura, K; Senda, M; Takahashi, N; Yao, R,
)
3.02
"Dehydroabietic acid (DHA) is an abundant resin acid in conifers, representing a natural wood protectant."( Differential patterns of dehydroabietic acid biotransformation by Nicotiana tabacum and Catharanthus roseus cells.
Häkkinen, ST; Lackman, P; Maaheimo, H; Nygrén, H; Oksman-Caldentey, KM; Rischer, H, 2012
)
1.4
"Dehydroabietic acid (DHAA) is a major aquatic toxic resin acid usually found in unbleached pulp mill effluents. "( Effects of dehydroabietic acid on the physical state of cytoskeletal proteins and the lipid bilayer of erythrocyte membranes.
Butterfield, DA; Hall, NC; Trad, CH, 1994
)
2.12

Effects

ExcerptReferenceRelevance
"Dehydroabietic acid derivatives have been reported to display antisecretory and antipepsin effect in animal models. "( Gastroprotective and cytotoxic effect of dehydroabietic acid derivatives.
Astudillo, L; Rodríguez, JA; Schmeda-Hirschmann, G; Sepúlveda, B; Theoduloz, C; Yáñez, T, 2005
)
2.04

Actions

ExcerptReferenceRelevance
"Dehydroabietic acid (DHAA) plays an important role in drug discovery. "( Synthesis and antimicrobial evaluation of novel analogues of dehydroabietic acid prepared by CH-Activation.
Berger, M; Maulide, N; Roller, A, 2017
)
2.14

Toxicity

Dehydroabietic acid and the oleoresin were the most toxic compounds followed by O-methylpodocarpic acid, whereas podocarpIC acid and tea tree oil showed a lower level of toxicity.

ExcerptReferenceRelevance
" Dose-response studies indicated that unbleached effluents contained more potent toxic substances than bleached effluents."( Toxic effects of bleached and unbleached paper mill effluents in primary cultures of rainbow trout hepatocytes.
Andersson, T; Pesonen, M, 1992
)
0.28
" Albumin slightly reduced the toxic effects, whereas the addition of zinc in various forms strongly inhibited these toxic effects of DHAA in the concentration range of 10-500 micrograms/mL."( Neutralizing effect of zinc oxide on dehydroabietic acid-induced toxicity on human polymorphonuclear leukocytes.
Hallmans, G; Hänström, L; Holm, SE; Reuterving, CO; Söderberg, TA; Sunzel, B, 1991
)
0.55
" Albumin slightly reduced the toxic effects, whereas the addition of zinc in various forms strongly inhibited these toxic effects of DHAA in the concentration range 10-500 micrograms/mL."( Neutralizing effect of zinc oxide on dehydroabietic acid-induced toxicity on human polymorphonuclear leukocytes.
Hallmans, G; Hänström, L; Holm, SE; Reuterving, CO; Söderberg, TA; Sunzel, B, 1991
)
0.55
" The fish kill was associated to the outbreak of infectious diseases, spring viremia of carp and saprolegniosis, related to an increase in the fish's susceptibility due to the presence of a toxic chemical."( Toxicity identification evaluations for the investigation of fish kills: a case study.
Blazquez, T; Carballo, M; Carbonell, G; Castaño, A; Muñoz, MJ; Ortiz, JA; Tarazona, JV; Vega, M, 1994
)
0.29
" Dehydroabietic acid and the oleoresin were the most toxic compounds followed by O-methylpodocarpic acid, whereas podocarpic acid and tea tree oil showed a lower level of toxicity."( Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells.
Gref, R; Johansson, A; Söderberg, TA, 1996
)
1.2
" Retene (10-320 microg l(-1)) was not acutely toxic in the dark."( Photoinduced toxicity of retene to Daphnia magna under enhanced UV-B radiation.
Huovinen, PS; Oikari, AO; Soimasuo, MR, 2001
)
0.31
" Herein, we discovered and developed four new self-assembled tricyclic diterpene acids NSMP with favorable anticancer activity for synergistic and safe antitumor chemotherapy, including dehydroabietic acid, 15-hydroxy-dehydroabietic acid, abietic acid, and 12-hydroxyabietic acid."( Self-assembled natural small molecule diterpene acids with favorable anticancer activity and biosafety for synergistically enhanced antitumor chemotherapy.
Cheng, J; Fu, S; Han, Y; Qin, Z; Yang, X, 2021
)
0.81

Bioavailability

ExcerptReferenceRelevance
"Triptolide is a valuable multipotent antitumor diterpenoid in Tripterygium wilfordii, and its C-14 hydroxyl group is often selected for modification to enhance both the bioavailability and antitumor efficacy."( Tandemly duplicated CYP82Ds catalyze 14-hydroxylation in triptolide biosynthesis and precursor production in Saccharomyces cerevisiae.
Gao, J; Gao, W; Hu, T; Huang, L; Li, D; Liu, Y; Lu, Y; Ma, L; Su, P; Tong, Y; Tu, L; Wang, J; Wu, X; Yin, Y; Zhang, Y; Zhao, H; Zhao, Y; Zhou, J, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Dose-response studies indicated that unbleached effluents contained more potent toxic substances than bleached effluents."( Toxic effects of bleached and unbleached paper mill effluents in primary cultures of rainbow trout hepatocytes.
Andersson, T; Pesonen, M, 1992
)
0.28
" Endpoints of those dose-response studies included critical swimming speed, oxygen consumption, and hematology."( Combined effects of pulp and paper effluent, dehydroabietic acid, and hypoxia on swimming performance, metabolism, and hematology of rainbow trout.
Bannon, HJ; Finley, M; Landman, MJ; Ling, N; van den Heuvel, MR, 2006
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
abietane diterpenoidA diterpenoid based on an abietane skeleton.
monocarboxylic acidAn oxoacid containing a single carboxy group.
carbotricyclic compoundA carbopolyclic compound comprising of three carbocyclic rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
dehydroabietic acid biosynthesis512
superpathway of diterpene resin acids biosynthesis523

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
G1/S-specific cyclin-E1Homo sapiens (human)IC50 (µMol)36.29000.00101.040410.0000AID1275126
Cyclin-dependent kinase 2Homo sapiens (human)IC50 (µMol)36.29000.00041.044410.0000AID1275126
Tyrosine-protein kinase JAK3Homo sapiens (human)IC50 (µMol)0.10000.00010.41937.9200AID1410147
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)IC50 (µMol)36.29000.00301.69437.0795AID1275126
Lysine--tRNA ligaseHomo sapiens (human)IC50 (µMol)0.02770.00090.30731.4740AID1410144
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinoic acid receptor RXR-alphaHomo sapiens (human)EC50 (µMol)42.00000.00010.34279.1000AID1355434
Retinoic acid receptor RXR-betaHomo sapiens (human)EC50 (µMol)42.00000.00080.52545.2000AID1355437
Retinoic acid receptor RXR-gammaHomo sapiens (human)EC50 (µMol)42.00000.00010.23801.2250AID1355440
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (90)

Processvia Protein(s)Taxonomy
positive regulation of cholesterol effluxRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of thyroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of bone mineralizationRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transporter activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
response to retinoic acidRetinoic acid receptor RXR-alphaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of vitamin D receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
cell differentiationRetinoic acid receptor RXR-alphaHomo sapiens (human)
anatomical structure developmentRetinoic acid receptor RXR-alphaHomo sapiens (human)
protein phosphorylationG1/S-specific cyclin-E1Homo sapiens (human)
G1/S transition of mitotic cell cycleG1/S-specific cyclin-E1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIG1/S-specific cyclin-E1Homo sapiens (human)
telomere maintenanceG1/S-specific cyclin-E1Homo sapiens (human)
DNA replication initiationG1/S-specific cyclin-E1Homo sapiens (human)
homologous chromosome pairing at meiosisG1/S-specific cyclin-E1Homo sapiens (human)
Wnt signaling pathwayG1/S-specific cyclin-E1Homo sapiens (human)
regulation of protein localizationG1/S-specific cyclin-E1Homo sapiens (human)
cell divisionG1/S-specific cyclin-E1Homo sapiens (human)
positive regulation of mesenchymal stem cell proliferationG1/S-specific cyclin-E1Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG1/S-specific cyclin-E1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleG1/S-specific cyclin-E1Homo sapiens (human)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICyclin-dependent kinase 2Homo sapiens (human)
DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
DNA repairCyclin-dependent kinase 2Homo sapiens (human)
chromatin remodelingCyclin-dependent kinase 2Homo sapiens (human)
DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
potassium ion transportCyclin-dependent kinase 2Homo sapiens (human)
centriole replicationCyclin-dependent kinase 2Homo sapiens (human)
Ras protein signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 2Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of heterochromatin formationCyclin-dependent kinase 2Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated DNA replication initiationCyclin-dependent kinase 2Homo sapiens (human)
telomere maintenance in response to DNA damageCyclin-dependent kinase 2Homo sapiens (human)
post-translational protein modificationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
centrosome duplicationCyclin-dependent kinase 2Homo sapiens (human)
cell divisionCyclin-dependent kinase 2Homo sapiens (human)
meiotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
cellular response to nitric oxideCyclin-dependent kinase 2Homo sapiens (human)
cellular senescenceCyclin-dependent kinase 2Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processCyclin-dependent kinase 2Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 2Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 2Homo sapiens (human)
hormone-mediated signaling pathwayRetinoic acid receptor RXR-betaHomo sapiens (human)
positive regulation of bone mineralizationRetinoic acid receptor RXR-betaHomo sapiens (human)
mRNA transcription by RNA polymerase IIRetinoic acid receptor RXR-betaHomo sapiens (human)
steroid hormone mediated signaling pathwayRetinoic acid receptor RXR-betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionRetinoic acid receptor RXR-betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-betaHomo sapiens (human)
positive regulation of vitamin D receptor signaling pathwayRetinoic acid receptor RXR-betaHomo sapiens (human)
anatomical structure developmentRetinoic acid receptor RXR-betaHomo sapiens (human)
cell differentiationRetinoic acid receptor RXR-betaHomo sapiens (human)
retinoic acid receptor signaling pathwayRetinoic acid receptor RXR-betaHomo sapiens (human)
response to retinoic acidRetinoic acid receptor RXR-betaHomo sapiens (human)
steroid hormone mediated signaling pathwayRetinoic acid receptor RXR-gammaHomo sapiens (human)
retinoic acid receptor signaling pathwayRetinoic acid receptor RXR-gammaHomo sapiens (human)
anatomical structure developmentRetinoic acid receptor RXR-gammaHomo sapiens (human)
response to retinoic acidRetinoic acid receptor RXR-gammaHomo sapiens (human)
cell differentiationRetinoic acid receptor RXR-gammaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-gammaHomo sapiens (human)
adaptive immune responseTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of dendritic cell cytokine productionTyrosine-protein kinase JAK3Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase JAK3Homo sapiens (human)
enzyme-linked receptor protein signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
tyrosine phosphorylation of STAT proteinTyrosine-protein kinase JAK3Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase JAK3Homo sapiens (human)
B cell differentiationTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of interleukin-10 productionTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of interleukin-12 productionTyrosine-protein kinase JAK3Homo sapiens (human)
intracellular signal transductionTyrosine-protein kinase JAK3Homo sapiens (human)
interleukin-15-mediated signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
interleukin-4-mediated signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
interleukin-2-mediated signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
interleukin-9-mediated signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
T cell homeostasisTyrosine-protein kinase JAK3Homo sapiens (human)
innate immune responseTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of FasL productionTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of T-helper 1 cell differentiationTyrosine-protein kinase JAK3Homo sapiens (human)
regulation of receptor signaling pathway via JAK-STATTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of T cell activationTyrosine-protein kinase JAK3Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein kinase JAK3Homo sapiens (human)
regulation of T cell apoptotic processTyrosine-protein kinase JAK3Homo sapiens (human)
negative regulation of thymocyte apoptotic processTyrosine-protein kinase JAK3Homo sapiens (human)
response to interleukin-2Tyrosine-protein kinase JAK3Homo sapiens (human)
response to interleukin-4Tyrosine-protein kinase JAK3Homo sapiens (human)
response to interleukin-15Tyrosine-protein kinase JAK3Homo sapiens (human)
response to interleukin-9Tyrosine-protein kinase JAK3Homo sapiens (human)
regulation of apoptotic processTyrosine-protein kinase JAK3Homo sapiens (human)
cell differentiationTyrosine-protein kinase JAK3Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATTyrosine-protein kinase JAK3Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein kinase JAK3Homo sapiens (human)
basophil activation involved in immune responseLysine--tRNA ligaseHomo sapiens (human)
positive regulation of inflammatory response to antigenic stimulusLysine--tRNA ligaseHomo sapiens (human)
lysyl-tRNA aminoacylationLysine--tRNA ligaseHomo sapiens (human)
tRNA processingLysine--tRNA ligaseHomo sapiens (human)
response to X-rayLysine--tRNA ligaseHomo sapiens (human)
diadenosine tetraphosphate biosynthetic processLysine--tRNA ligaseHomo sapiens (human)
positive regulation of macrophage activationLysine--tRNA ligaseHomo sapiens (human)
positive regulation of DNA-templated transcriptionLysine--tRNA ligaseHomo sapiens (human)
ERK1 and ERK2 cascadeLysine--tRNA ligaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (45)

Processvia Protein(s)Taxonomy
vitamin D response element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription coregulator bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear steroid receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
zinc ion bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
enzyme bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
peptide bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
identical protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear vitamin D receptor bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid-responsive element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA binding domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
LBD domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
protein bindingG1/S-specific cyclin-E1Homo sapiens (human)
kinase activityG1/S-specific cyclin-E1Homo sapiens (human)
protein kinase bindingG1/S-specific cyclin-E1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG1/S-specific cyclin-E1Homo sapiens (human)
histone kinase activityCyclin-dependent kinase 2Homo sapiens (human)
magnesium ion bindingCyclin-dependent kinase 2Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein bindingCyclin-dependent kinase 2Homo sapiens (human)
ATP bindingCyclin-dependent kinase 2Homo sapiens (human)
protein domain specific bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificRetinoic acid receptor RXR-betaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificRetinoic acid receptor RXR-betaHomo sapiens (human)
nuclear steroid receptor activityRetinoic acid receptor RXR-betaHomo sapiens (human)
nuclear receptor activityRetinoic acid receptor RXR-betaHomo sapiens (human)
protein bindingRetinoic acid receptor RXR-betaHomo sapiens (human)
zinc ion bindingRetinoic acid receptor RXR-betaHomo sapiens (human)
sequence-specific double-stranded DNA bindingRetinoic acid receptor RXR-betaHomo sapiens (human)
retinoic acid-responsive element bindingRetinoic acid receptor RXR-betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificRetinoic acid receptor RXR-gammaHomo sapiens (human)
nuclear steroid receptor activityRetinoic acid receptor RXR-gammaHomo sapiens (human)
protein bindingRetinoic acid receptor RXR-gammaHomo sapiens (human)
zinc ion bindingRetinoic acid receptor RXR-gammaHomo sapiens (human)
molecular condensate scaffold activityRetinoic acid receptor RXR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingRetinoic acid receptor RXR-gammaHomo sapiens (human)
nuclear receptor activityRetinoic acid receptor RXR-gammaHomo sapiens (human)
retinoic acid-responsive element bindingRetinoic acid receptor RXR-gammaHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase JAK3Homo sapiens (human)
protein bindingTyrosine-protein kinase JAK3Homo sapiens (human)
ATP bindingTyrosine-protein kinase JAK3Homo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase JAK3Homo sapiens (human)
growth hormone receptor bindingTyrosine-protein kinase JAK3Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase JAK3Homo sapiens (human)
tRNA bindingLysine--tRNA ligaseHomo sapiens (human)
ATP:ADP adenylyltransferase activityLysine--tRNA ligaseHomo sapiens (human)
lysine-tRNA ligase activityLysine--tRNA ligaseHomo sapiens (human)
protein bindingLysine--tRNA ligaseHomo sapiens (human)
ATP bindingLysine--tRNA ligaseHomo sapiens (human)
amino acid bindingLysine--tRNA ligaseHomo sapiens (human)
identical protein bindingLysine--tRNA ligaseHomo sapiens (human)
protein homodimerization activityLysine--tRNA ligaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (31)

Processvia Protein(s)Taxonomy
nucleusRetinoic acid receptor RXR-alphaHomo sapiens (human)
nucleoplasmRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
mitochondrionRetinoic acid receptor RXR-alphaHomo sapiens (human)
cytosolRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
chromatinRetinoic acid receptor RXR-alphaHomo sapiens (human)
receptor complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
nucleusG1/S-specific cyclin-E1Homo sapiens (human)
nucleoplasmG1/S-specific cyclin-E1Homo sapiens (human)
cytosolG1/S-specific cyclin-E1Homo sapiens (human)
cyclin E1-CDK2 complexG1/S-specific cyclin-E1Homo sapiens (human)
centrosomeG1/S-specific cyclin-E1Homo sapiens (human)
nucleusG1/S-specific cyclin-E1Homo sapiens (human)
cytoplasmG1/S-specific cyclin-E1Homo sapiens (human)
chromosome, telomeric regionCyclin-dependent kinase 2Homo sapiens (human)
condensed chromosomeCyclin-dependent kinase 2Homo sapiens (human)
X chromosomeCyclin-dependent kinase 2Homo sapiens (human)
Y chromosomeCyclin-dependent kinase 2Homo sapiens (human)
male germ cell nucleusCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
nuclear envelopeCyclin-dependent kinase 2Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
endosomeCyclin-dependent kinase 2Homo sapiens (human)
centrosomeCyclin-dependent kinase 2Homo sapiens (human)
cytosolCyclin-dependent kinase 2Homo sapiens (human)
Cajal bodyCyclin-dependent kinase 2Homo sapiens (human)
cyclin A1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin A2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 2Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
nucleusRetinoic acid receptor RXR-betaHomo sapiens (human)
nucleoplasmRetinoic acid receptor RXR-betaHomo sapiens (human)
nucleolusRetinoic acid receptor RXR-betaHomo sapiens (human)
cytosolRetinoic acid receptor RXR-betaHomo sapiens (human)
RNA polymerase II transcription regulator complexRetinoic acid receptor RXR-betaHomo sapiens (human)
chromatinRetinoic acid receptor RXR-betaHomo sapiens (human)
nucleoplasmRetinoic acid receptor RXR-gammaHomo sapiens (human)
cytoplasmRetinoic acid receptor RXR-gammaHomo sapiens (human)
chromatinRetinoic acid receptor RXR-gammaHomo sapiens (human)
RNA polymerase II transcription regulator complexRetinoic acid receptor RXR-gammaHomo sapiens (human)
extrinsic component of plasma membraneTyrosine-protein kinase JAK3Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneTyrosine-protein kinase JAK3Homo sapiens (human)
endosomeTyrosine-protein kinase JAK3Homo sapiens (human)
cytosolTyrosine-protein kinase JAK3Homo sapiens (human)
cytoskeletonTyrosine-protein kinase JAK3Homo sapiens (human)
plasma membraneTyrosine-protein kinase JAK3Homo sapiens (human)
cytosolTyrosine-protein kinase JAK3Homo sapiens (human)
extracellular spaceLysine--tRNA ligaseHomo sapiens (human)
nucleusLysine--tRNA ligaseHomo sapiens (human)
mitochondrionLysine--tRNA ligaseHomo sapiens (human)
mitochondrial matrixLysine--tRNA ligaseHomo sapiens (human)
cytosolLysine--tRNA ligaseHomo sapiens (human)
plasma membraneLysine--tRNA ligaseHomo sapiens (human)
aminoacyl-tRNA synthetase multienzyme complexLysine--tRNA ligaseHomo sapiens (human)
extracellular spaceLysine--tRNA ligaseHomo sapiens (human)
cytosolLysine--tRNA ligaseHomo sapiens (human)
nucleusLysine--tRNA ligaseHomo sapiens (human)
mitochondrionLysine--tRNA ligaseHomo sapiens (human)
nucleoplasmLysine--tRNA ligaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (136)

Assay IDTitleYearJournalArticle
AID1295874Cytotoxicity in human A549 cells by SRB assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID1175297Antifungal activity against Trametes versicolor after 3 to 5 days by paper disc method relative to 12272015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Quantitative structure-activity relationship of antifungal activity of rosin derivatives.
AID471490Cytotoxicity against african green monkey Vero cells assessed as minimal toxic dosed detached 100% of the cell monolayer2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1076718Cytotoxicity against human Bel7404 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID332338Antimicrobial activity against Bacillus subtilis 327 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID1174411Cytotoxicity against human HL7702 cells after 48 hrs by MTT assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
AID1410134Inhibition of JAK3 (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1491120Anticonvulsant activity in 7-days post fertilized zebra fish larvae assessed as reduction in pentylenetetrazol-induced locomotor activity by measuring total distance traveled by larvae at 1.5 to 6 uM pretreated for 3 hrs followed by pentylenetetrazol addi2017Journal of natural products, 05-26, Volume: 80, Issue:5
HPLC-Based Activity Profiling for GABA
AID1275098Cytotoxic activity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID332341Antimicrobial activity against Escherichia coli imp 389 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID1410135Inhibition of ZAP70 (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID471481Antifungal activity against Aspergillus terreus after 24 hrs by AFST-EUCAST method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1355441Transactivation of human Gal4-fused RXRgamma LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay relative to bexarotene2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1378663Inhibition of recombinant human MMP3 (Tyr18 to Cys477 residues) expressed in mouse myeloma cells using Mca-Pro-LeuGly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID398026Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 100 mol ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Potential antitumor-promoting diterpenes from the cones of Pinus luchuensis.
AID457057Inhibition of TNF-alpha-induced NF-kappaB activity in human pNF-kappaB-luc-293 cells2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr.
AID1076720Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID755551Cytotoxicity against human Jurkat cells assessed as growth inhibition after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anticancer effects of a novel class rosin-derivatives with different mechanisms.
AID1392011Antistaphylococcal activity against erythromycin-resistant Staphylococcus aureus NRS-70 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1431162Antibacterial activity against Staphylococcus aureus Newman after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID1374759Cytotoxicity against HUVEC assessed as reduction in cell viability up to 100 uM after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
7α,15-Dihydroxydehydroabietic acid from Pinus koraiensis inhibits the promotion of angiogenesis through downregulation of VEGF, p-Akt and p-ERK in HUVECs.
AID1410147Inhibition of JAK3 (unknown origin) by mobility shift assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1378665Inhibition of recombinant human MMP9 (Ala20 to Asp707 residues) expressed in CHO cells using Mca-Pro-LeuGly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID1378664Inhibition of recombinant human MMP8 (Phe21 to Gly467 residues) expressed in mouse myeloma cells using Mca-Pro-LeuGly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID1355457Transactivation of RXR in human HepG2 cells assessed as induction of ABCA1 mRNA expression at 30 uM after 8 hrs by qRT-PCR analysis2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1295870Neuroprotective activity in rat C6 cells assessed as induction of NGF release at 20 uM after 24 hrs by ELISA2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID471488Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for human Jurkat cells2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID471484Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1355434Transactivation of human Gal4-fused RXRalpha LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1355435Transactivation of human Gal4-fused RXRalpha LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay relative to bexarotene2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1172521Antiulcer activity in rat assessed as inhibition of secretion at 30 mg/kg, ip2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthetic derivatives of aromatic abietane diterpenoids and their biological activities.
AID381370Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 10 mol ratio relative to TPA2000Journal of natural products, Jun, Volume: 63, Issue:6
Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni.
AID1378670Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID774810Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
AID1392014Antistaphylococcal activity against linezolid-resistant Staphylococcus aureus NRS-271 containing phage type E-MRSA 15 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID755528Cytotoxicity against human 5637 cells assessed as growth inhibition after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anticancer effects of a novel class rosin-derivatives with different mechanisms.
AID1378667Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID1410132Inhibition of PKA (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1431168Antibacterial activity against Escherichia coli AB1157 at 50 ug/ml after 18 hrs by two fold serial dilution method2017European journal of medicinal chemistry, Feb-15, Volume: 127The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.
AID1275126Inhibition of human recombinant C-terminal His6-tagged full length human Cdk2/human recombinant N-terminal GST-tagged full-length Cyclin E using histone H1 substrate after 40 mins by radiometric filter binding assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID1867227Toxicity against human MIA PaCa-2 cells in nutrient-rich medium (DMEM)2022Bioorganic & medicinal chemistry letters, 06-15, Volume: 66Abietane diterpenes from Abies spectabilis and their anti-pancreatic cancer activity against the MIA PaCa-2 cell line.
AID755529Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anticancer effects of a novel class rosin-derivatives with different mechanisms.
AID1355440Transactivation of human Gal4-fused RXRgamma LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1174408Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
AID1295871Cytotoxicity in rat C6 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID1355447Transactivation of human Gal4-fused PPARgamma LBD expressed in HEK293T cells at 30 uM after 12 to 14 hrs by dual-glo luciferase assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1378668Antiproliferative activity against human SKOV3 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID1410130Inhibition of PKCdelta (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1275097Cytotoxic activity against human A549 cells assessed as inhibition of cell growth after 48 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID1355433Transactivation of human Gal4-fused RXRalpha LBD expressed in HEK293T cells at 30 uM after 12 to 14 hrs by dual-glo luciferase assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID471493Antiviral activity against Human herpesvirus 1 infected in human HeLa cells assessed as ratio of viral titer in absence of drug over viral titer in presence of drug after 36 hrs by end point titration method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1410139Inhibition of PIM1 (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID398024Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 1000 mol ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Potential antitumor-promoting diterpenes from the cones of Pinus luchuensis.
AID1392012Antistaphylococcal activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-100 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1410128Inhibition of FAK (unknown origin) at 50 ug/ml by Lanthascreen assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1368175Antibacterial activity against Bacillus subtilis measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
Identification of a diverse synthetic abietane diterpenoid library and insight into the structure-activity relationships for antibacterial activity.
AID1325496Antibacterial activity against erythromycin-resistant Staphylococcus aureus NRS-702016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1076719Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID1378666Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID471486Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1410131Inhibition of SYK (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1374760Antiangiogenic activity against HUVEC assessed as reduction in tube formation at 12.5 uM after 24 hrs by matrigel-based light microscopic analysis relative to control2018Bioorganic & medicinal chemistry letters, 04-01, Volume: 28, Issue:6
7α,15-Dihydroxydehydroabietic acid from Pinus koraiensis inhibits the promotion of angiogenesis through downregulation of VEGF, p-Akt and p-ERK in HUVECs.
AID1325497Antibacterial activity against oxacillin/tetracycline-resistant Staphylococcus aureus NRS-1002016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1175298Antifungal activity against Gloeophyllum trabeum after 3 to 5 days by paper disc method relative to 12272015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Quantitative structure-activity relationship of antifungal activity of rosin derivatives.
AID1246300Cytotoxicity against human HepG2 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1275095Cytotoxic activity against human SKOV3 cells assessed as inhibition of cell growth after 48 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID1295875Cytotoxicity in human SKOV3 cells by SRB assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID1172523Gastroprotective activity in mouse assessed as reduction in HCl/EtOH-induced gastric lesions at 100 mg/kg2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthetic derivatives of aromatic abietane diterpenoids and their biological activities.
AID774807Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
AID1355458Transactivation of RXR in human HepG2 cells assessed as induction of apoE mRNA expression at 30 uM after 8 hrs by qRT-PCR analysis2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID776386Cytotoxicity against human NCI-H460 cells after 3 days by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
AID1295876Cytotoxicity in human SK-MEL-2 cells by SRB assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID471494Antiviral activity against Human herpesvirus 1 infected in human HeLa cells assessed as maximal nontoxic dose caused highest viral reduction factor after 36 hrs by end point titration method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1410138Inhibition of GSK3b (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1867226Preferential cytotoxicity against human MIA PaCa-2 cells in nutrient-deprived medium2022Bioorganic & medicinal chemistry letters, 06-15, Volume: 66Abietane diterpenes from Abies spectabilis and their anti-pancreatic cancer activity against the MIA PaCa-2 cell line.
AID1368176Antibacterial activity against Escherichia coli measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
Identification of a diverse synthetic abietane diterpenoid library and insight into the structure-activity relationships for antibacterial activity.
AID1325495Antibacterial activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-12016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1434299Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
AID1246298Antiproliferative activity against human triple-negative MDA-MB-231 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1410133Inhibition of ALK (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1368177Antibacterial activity against Pseudomonas fluorescens measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
Identification of a diverse synthetic abietane diterpenoid library and insight into the structure-activity relationships for antibacterial activity.
AID1325494Antibacterial activity against Staphylococcus aureus Newman2016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID381371Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio/TPA2000Journal of natural products, Jun, Volume: 63, Issue:6
Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni.
AID1378669Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
AID332340Antimicrobial activity against methicillin-resistant Staphylococcus aureus 310 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID1392013Antistaphylococcal activity against gentamicin-resistant Staphylococcus aureus NRS-108 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1295877Cytotoxicity in human HCT116 cells by SRB assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID1410140Inhibition of PDK1 (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1410136Inhibition of SRC (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1392010Antistaphylococcal activity against aminoglycosides/tetracycline-resistant Staphylococcus aureus NRS-1 after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1434297Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
AID381368Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 500 mol ratio relative to TPA2000Journal of natural products, Jun, Volume: 63, Issue:6
Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni.
AID381367Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 1000 mol ratio relative to TPA2000Journal of natural products, Jun, Volume: 63, Issue:6
Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni.
AID1355437Transactivation of human Gal4-fused RXRbeta LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID1392009Antistaphylococcal activity against Staphylococcus aureus Newman after 18 hrs by two-fold serial dilution method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
AID1275096Cytotoxic activity against human Bel7404 cells assessed as inhibition of cell growth after 48 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID1174410Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
AID1325498Antibacterial activity against gentamicin-resistant Staphylococcus aureus NRS-1082016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID471478Antifungal activity against Candida krusei ATCC 6258 at <100 ug/ml after 24 hrs by AFST-EUCAST method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID774809Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
AID1246299Cytotoxicity against HEK293 cells at <= 50 uM after 72 hrs by CellTiter-Glo assay2015European journal of medicinal chemistry, Sep-18, Volume: 102(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
AID1076716Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID1076721Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID776387Cytotoxicity against human A549 cells after 3 days by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
AID1275099Cytotoxic activity against human NCI-H460 cells assessed as inhibition of cell growth after 48 hrs by MTT assay2016European journal of medicinal chemistry, Jan-27, Volume: 108Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
AID1410144Inhibition of SYK (unknown origin) by mobility shift assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID332339Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 375 after 18 hrs by microbroth dilution method2003Journal of natural products, Feb, Volume: 66, Issue:2
Antibacterial diterpenes from Calceolaria pinifolia.
AID1410137Inhibition of AKT1 (unknown origin) at 50 ug/ml by mobility shift assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID1174409Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
AID776384Cytotoxicity against human HepG2 cells after 3 days by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
AID1355438Transactivation of human Gal4-fused RXRbeta LBD expressed in HEK293T cells after 12 to 14 hrs by dual-glo luciferase assay relative to bexarotene2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID471480Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml after 24 hrs by AFST-EUCAST method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID471487Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for human HeLa cells2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1410129Inhibition of BRAF (unknown origin) at 50 ug/ml by Lanthascreen assay relative to control2018Journal of natural products, 04-27, Volume: 81, Issue:4
Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors.
AID457056Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO release2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr.
AID776385Cytotoxicity against human SKOV3 cells after 3 days by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
AID1491116Toxicity in 7-days post fertilized zebra fish larvae after 1.5 to 24 hrs by microscopic analysis2017Journal of natural products, 05-26, Volume: 80, Issue:5
HPLC-Based Activity Profiling for GABA
AID1295872Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Diterpenes from the Trunk of Abies holophylla and Their Potential Neuroprotective and Anti-inflammatory Activities.
AID471485Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID1355456Cytotoxicity against human HepG2 cells assessed as reduction in cell viability up to 100 uM after 48 hrs by WST1 assay2018Journal of medicinal chemistry, 06-28, Volume: 61, Issue:12
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.
AID398027Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 10 mol ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Potential antitumor-promoting diterpenes from the cones of Pinus luchuensis.
AID381369Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 100 mol ratio relative to TPA2000Journal of natural products, Jun, Volume: 63, Issue:6
Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni.
AID1751494Antibiofilm activity against Staphylococcus aureus assessed as inhibition of biofilm formation at 60 uM2021Bioorganic & medicinal chemistry letters, 09-15, Volume: 48Discovery of non-proteinogenic amino acids inhibiting biofilm formation by S. aureus and methicillin-resistant S. aureus.
AID755527Cytotoxicity against human EJ cells assessed as growth inhibition after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anticancer effects of a novel class rosin-derivatives with different mechanisms.
AID1434295Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
AID471477Antifungal activity against Candida parapsilosis ATCC 22019 at <100 ug/ml after 24 hrs by AFST-EUCAST method2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis and biological evaluation of dehydroabietic acid derivatives.
AID457058Antiproliferative activity against human LoVo cells2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr.
AID755553Cytotoxicity against human HeLa cells assessed as growth inhibition after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anticancer effects of a novel class rosin-derivatives with different mechanisms.
AID398028Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio after 48 hours relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Potential antitumor-promoting diterpenes from the cones of Pinus luchuensis.
AID774808Cytotoxicity against human A549 cells after 48 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
AID398025Inhibition of 12-O-tetradecanoylphorbol 13-acetate-induced Epstein-Barr virus early antigen activation in human Raji cells assessed as EA induction at 500 mol ratio relative to TPA2002Journal of natural products, Dec, Volume: 65, Issue:12
Potential antitumor-promoting diterpenes from the cones of Pinus luchuensis.
AID1368174Antibacterial activity against Staphylococcus aureus measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
Identification of a diverse synthetic abietane diterpenoid library and insight into the structure-activity relationships for antibacterial activity.
AID1076717Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
AID457055Antiproliferative activity against human QGY7703 cells2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Isolation, structure, and bioactivities of abiesadines A-Y, 25 new diterpenes from Abies georgei Orr.
AID1325499Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS-2712016Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22
The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (210)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (7.14)18.7374
1990's30 (14.29)18.2507
2000's56 (26.67)29.6817
2010's83 (39.52)24.3611
2020's26 (12.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.54 (24.57)
Research Supply Index5.37 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index51.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (2.34%)6.00%
Case Studies1 (0.47%)4.05%
Observational0 (0.00%)0.25%
Other208 (97.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]